Ibi351 Monotherapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ibi351 Monotherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ibi351 Monotherapy Today - Breaking & Trending Today

IBI351 Receives Breakthrough Therapy Designation in China for Previously Treated Advanced CRC

Published: May 16, 2023

China’s National Medical Products Administration has granted a breakthrough therapy designation to the KRAS G12C inhibitor IBI351 as monotherapy for previously treated patients with advanced colorectal carcinoma harboring a KRAS G12C mutation.

Source: onclive.com

Related Topics:

Rhui ZhouChina National Medical Products AdministrationNational Medical Products AdministrationIbi351 Patients With Advanced Colorectal CarcinomaIbi351 MonotherapyPatients With Advanced Nsclc And Gastrointestinal Tumors